We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
MedicalSystem

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Insulin Sensitivity and Adiponectin Level Predict Insulin Therapy Response

By LabMedica International staff writers
Posted on 03 Oct 2019
Print article
Image: Consistent HbA1c improvement was associated with higher insulin sensitivity in the TODAY study (Photo courtesy of Diabnext).
Image: Consistent HbA1c improvement was associated with higher insulin sensitivity in the TODAY study (Photo courtesy of Diabnext).
A cohort of youths with obesity and type 2 diabetes who initiated insulin therapy experienced highly variable HbA1c outcomes, with greater insulin sensitivity and higher adiponectin levels associated with improved glycemic response.

Previous evaluation of risk factors for glycemic failure in the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study indicated that higher failure rates were associated with beta-cell dysfunction, higher HbA1c at randomization and African American race. The change in total and high molecular weight adiponectin concentrations over the first six months post-randomization in TODAY was predictive of the responsiveness to oral diabetes therapy.

Scientists at the Baylor College of Medicine (Houston, TX, USA) and their associates analyzed data from 253 youths aged 10 to 17 years with obesity and type 2 diabetes for at least two years participating in TODAY study who were enrolled between July 2004 and February 2009, who had a mean of 3.9 visits since initiation of insulin therapy (64% girls; mean age at randomization, 14 years; mean HbA1c at insulin initiation, 10.1%).

Insulin glargine was titrated up to 1 U/kg per day (maximum, 100 U) until fasting glucose levels measured by self-monitoring reached 70 mg/dL to 150 mg/dL. Add-on insulin glargine therapy was considered unsuccessful if titration of therapy did not bring fasting blood glucose to target within one month or if HbA1c was greater than 8% at three months or 7% at six months.

The team reported that within 1‐year post-insulin initiation, 33.2% of participants had a consistent HbA1c decrease of ≥0.5%, 46.2% changed HbA1c <0.5%, and 20.6% had an increase ≥0.5%. At randomization into TODAY and at time of insulin initiation, the three glycemia groups were similar in age, sex, race‐ethnicity, pubertal stage, BMI z‐score, diabetes duration, and insulin secretion indices. Consistent HbA1c improvement was associated with higher insulin sensitivity (1/fasting insulin) at randomization and at time of failure, higher adiponectin at randomization, and was not associated with indices of β‐cell function.

The authors concluded that response to add‐on insulin was highly variable among youth in the TODAY study. Greater insulin sensitivity and higher adiponectin concentrations at randomization were associated with improved glycemic control after initiation of insulin. Fida Bacha, MD, an associate professor of pediatrics and nutrition and first author of the study, said, “Youth with type 2 diabetes who required insulin therapy continued to have worse diabetes control over time compared with those who maintained glycemic control on metformin alone.” The study was originally published online on August 16, 2019, in the journal Pediatric Diabetes.

Related Links:
Baylor College of Medicine

Gold Supplier
SARS-CoV-2 Assay
INgezim COVID 19 SPIKE CROM
New
Intact Brentuximab Vedotin “Sandwich” Test
EDI Intact Brentuximab Vedotin ELISA Kit
New
Hepatitis B IgM ELISA
Anti-HBclgM
New
Fecal Occult Blood Test
iFOB Assay

Print article
SUGENTECH INC.

Channels

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more

Industry

view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.